This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Makul Singh: Innovator in Recombinant Protein Technology
Introduction
Makul Singh is a notable inventor based in Teaneck, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. His innovative work has led to advancements in medical treatments and therapeutic applications.
Latest Patents
Makul Singh holds a patent for a "Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof." This invention relates to a chimeric nucleic acid molecule encoding a fusion protein that combines a human lutropin hormone-receptor domain with a human chorionic gonadotropin-β subunit domain. The patent also covers the isolated fusion protein, antibodies that recognize its domains, and compositions that include the fusion protein along with pharmaceutical carriers. Furthermore, the invention outlines methods for treating androgen-excess-mediated diseases and immunocontraception techniques.
Career Highlights
Makul Singh is associated with the Cornell Research Foundation Inc., where he continues to explore and develop innovative solutions in biotechnology. His work has garnered attention for its potential impact on medical science and therapeutic interventions.
Collaborations
Makul has collaborated with notable colleagues, including Brij B Saxena and Premila Rathnam, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Makul Singh's contributions to recombinant protein technology exemplify the intersection of science and innovation. His patent and ongoing research hold promise for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
